NDC 87625-110 - SurviveX Travel Med MOD
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87625-110
- Manufacturer
- Intent Brands LLC
- Effective date
- 2026-08-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SurviveX Travel Med MOD - Intent Brands LLC | Intent Brands LLC | 2026-08-04 | HUMAN OTC DRUG LABEL |
| SurviveX Travel Med Kit - Intent Brands LLC | Intent Brands LLC | 2026-05-07 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen Diphenhydramine HCl | ACETAMINOPHEN DIPHENHYDRAMINE HCL | Chain Drug Consortium,LLC | 47f839b9-ac8a-161c-e054-00144ff8d46c | 2017-02-07 | Warnings | 362O9ITL9D |
| Cold Medicine | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Selder, S.A. de C.V. | d2762d9c-e7e7-42b2-a26a-14b2aa0307cb | 2017-01-25 | Warnings | M012 04JA59TNSJ 362O9ITL9D |
| SED-MAX | ACETAMINOPHEN 500 MG WITH CAFFEINE 65MG | Command Brands, LLC | 4920a0e9-6f88-4df0-8657-77c95a3b9617 | 2017-01-19 | Warnings | M013 362O9ITL9D |
| Allergy | CHLORPHENIRAMINE MALEATE | Marc Glassman, Inc. | 2051247f-ce64-4cf5-b449-9ca14c43ab86 | 2016-12-27 | Warnings | M012 |
| Allergy | LORATADINE | Selder, S.A. de C.V. | afdb0117-dd2d-4ab1-a2f4-2a88b6bf5251 | 2016-12-22 | Warnings | 311372 7AJO3BO7QN |
| BRONCOCHEM EXPECTORANT II | ACETAMINOPHEN-CHLORPHENIRAMINE MALEATE-DEXTROMETHORPHAN HBR-GUAIFENESIN-PHENYLEPHRINE HCL | LABORATORIO MAGNACHEM INTERNATIONAL SRL | d0426469-9dd1-4bd1-b81e-69d33187daa2 | 2016-12-19 | Warnings | 04JA59TNSJ 362O9ITL9D |
| Bismuth Chewable | BISMUTH SUBSALICYLATE 262 MG | Marc Glassman, Inc. | cdfcfdc2-ed5e-49d8-b16f-e32748d82e3e | 2016-12-19 | Warnings | M008 308761 62TEY51RR1 |
| Loperamide Hydrochloride | LOPERAMIDE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 8bf47ac3-746f-47c3-82b2-32ac979ff963 | 2016-11-30 | Boxed warning, Warnings, Adverse reactions | 77TI35393C |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Epic Pharma, LLC | 15437a72-24e5-4ef2-b1ea-8d8c0acbcd4c | 2016-11-22 | Warnings | TC2D6JAD40 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Epic Pharma, LLC | a083dec1-d4a7-4573-8a14-f5739d5bf153 | 2016-11-22 | Warnings | TC2D6JAD40 |
| CVS Health Four Actions Nasal Decongestant | PHENYLEPHRINE HYDROCHLORIDE | CVS Pharmacy,Inc. | c91b5525-6afb-4fea-afcb-9c4578075975 | 2016-09-22 | Warnings | 04JA59TNSJ |
| Antacid Relief | CALCIUM CARBONATE | Safeway | ead5101d-761a-4d1d-b14b-4dd548d2def6 | 2016-01-22 | Warnings | H0G9379FGK |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | XF417D3PSL | |
| Butalbital, Acetaminophen, and Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Actavis Pharma, Inc. | a6cbc17f-5c60-489c-8029-84b0add556d8 | 2014-08-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Loratadine | LORATADINE | Mylan Pharmaceuticals Inc. | 3b307aea-5a68-4c82-959a-cda4ffbd0a4a | 2013-11-15 | Warnings | 311372 7AJO3BO7QN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.